Volume : 09, Issue : 03, March – 2021
16.CHANGES IN THE LOCAL AND SYSTEM IMMUNE RESPONSE IN WOMEN WITH CHRONIC ENDOMETRITIS
Yu.A. Petrov and A.D. Kupina.
Abstract :
Aim: To analyze the features of changes in the immune response both at the local and systemic levels in patients with chronic endometritis (CE). Assess the state of cellular and immune components of the immune system in women with CE.
Materials and methods: The study reveals in detail the variability of immunological rearrangement in 450 women with different macro types of CE (hypoplastic, hyperplastic, mixed). The following indicators were analyzed to assess the state of the immune system: T-lymphocytes (CD 3+), B-lymphocytes (CD 20+), T-helpers (CD 4+), NK-cells (CD 16+), cytotoxic T-cells (CD 8+), rFAS-CD 95+ (apoptosis receptor), phagocytosis activity of monocytes and neutrophils. The above parameters were evaluated in the control group. There were 65 women with an early reproductive loss in history, but without chronic endometritis.
Results: The results of the data showed that the greatest decrease in resistance and inhibition of immunological rearrangement was observed in a cohort with a hyperplastic variant of CE. Hyperreactivity of the immune system was characteristic of women with mixed macro types. The pro-apoptotic orientation of changes, inhibition of cellular and humoral units was revealed in a cohort with hypoplastic macro types of CE. The role of persistent microbial pathogen in the development of immune deficiency was studied. The results of the study detail the importance of destructive-inflammatory, autoimmune processes, the imbalance of the cellular and humor parts of the immune system in the initiation and maintenance of CE.
Conclusions: The detailed study of the reaction of cellular and humoral defense factors, both at the local and systemic levels, will optimize the choice of pathogenetic therapy, interrupt the vicious cycle of persistent chronic inflammatory process in endometrial tissues, and also make an individual selection of rehabilitation measures in women with a complicated obstetric history.
Key words: chronic endometritis, immune response, macro types, immunological rearrangement, diagnostics.
Cite This Article:
Please cite this article in press Yu.A. Petrov and A.D. Kupina., Changes In The Local And System Immune Response In Women With Chronic Endometritis.,Indo Am. J. P. Sci, 2021; 08(03).
Number of Downloads : 10
References:
2. Petrov YuA, Rymashevsky NV, Kovaleva EA. Endometrial condition with intrauterine contraception. Problems of maternity and child care, 1988;3:59-62
3. Petrov YuA, Kovaleva EA. The valid duration of use plastic intrauterine contraceptives. Obstetrics and gynecology, 1986; 7: 40-42.
4. Kupina AD, Petrov YuA. Efficiency of sonographic research in diagnostics of chronic endometritis. Indo American Journal of Pharmaceutical Sciences, 2019; 6(11):15210-15213.
5. Petrov YuA, Kovaleva EA. The valid duration of use plastic intrauterine contraceptives. Obstetrics and Gynecology, 1986; 7: 40
6. Altmae S. Commentary: Uterine Microbiota: Residents, Tourists, or Invaders? Front Immunol, 2018; 9: 1874.
7. Arabestani MR, Fazzeli H, Nasr Esfahani B. Identification of the most common pathogenic bacteria in patients with suspected sepsis by multiplex PCR. J Infect Dev Ctries, 2014;8:461-8.
8. Petrov YuA. The content of DNA in the cells of the endometrial glands with the use of intrauterine contraceptives. Problems of maternity and child care, 1984;7: 64
9. Bouet PE, El Hachem H, Monceau E, et al. Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril, 2016;105:106–110.
10. Petrov YuA, Kovaleva EA. Features of colpocytograms of women using intrauterine contraception. Klinicheskaya Laboratornaya Diagnostika, 1986;1: 51-52.
11. Chen YQ, Fang RL, Luo YN, Luo CQ. Analysis of the diagnostic value of CD138 for chronic endometritis, the risk factors for the pathogenesis of chronic endometritis and the effect of chronic endometritis on pregnancy: A cohort study. BMC Womens Health, 2016; 16: 60.
12. Cicinelli E, Matteo M, Tinelli R, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod, 2015; 30: 323– 330.
13. Petrov YuA. Features of hyperplastic processes of the uterine mucosa in women using intrauterine contraceptives. Problems of maternity and child care, 1985; 11:67
14. Di Spiezio Sardo A, Di Carlo C, Minozzi S, et al. Efficacy of hysteroscopy in improving reproductive outcomes of infertile couples: a systematic review and meta-analysis. Hum Reprod Update, 2016;22:479–496.
15. Radzinsky VE, Kostin IN, Polina ML, Petrov YuA, Gasanova BM. Diagnostic significance of chronic endometritis macrotypes differentiation among women with reproductive losses. Gynecological Endocrinology, 2017; 33(1): 36-40.
16. Kamińska D, Gajecka M. Is the role of human female reproductive tract microbiota underestimated? Benef Microbes, 2017; 8:327–433.
17. Kitaya K, Matsubayashi H, Yamaguchi K, et al. Chronic endometritis: potential cause of infertility and obstetric and neonatal complications. Am J Reprod Immunol, 2016;75:13–22.
18. Petrov YuA. Oncological risk assessment of intrauterine contraception based on cytological studies of the endometrium. Problems in oncology, 1985;12:53-56.
19. Kitaya K, Takeuchi T, Mizuta S, et al. Endometritis: new time, new concepts. Fertility and Sterility, 2018;110(3):344–350.
20. Kushnir VA, Solouki S, Sarig-Meth T, Vega M. Systemic Inflammation and Autoimmunity in Women with Chronic Endometritis. American Journal Of Reproductive Immunology, 2016; 75(6):672-677.
21. Lee SK, Kim CJ, Kim DJ, Kang JH. Immune cells in the female reproductive tract. Immune Netw, 2015; 15: 16– 26.
22. Liu Y, Chen X, Huang J, et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil Steril, 2018; 109: 832– 839.
23. Petrov YuA, Kovaleva EA. Proliferative mucosal changes of the corpus and cervix uteri in women using intrauterine contraceptives. Problems in oncology. 1986; 32: 49-52.
24. Petrov YuA, Dolzhenkova LM. Histochemical examination of glycogen in the endometrium of women using intrauterine contraceptives. Obstetrics & Gynecology. 1985; 9: 57.
25. Moreno I, Cicinelli E, Garcia-Grau I, et al. The diagnosis of chronic endometritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology. American Journal of Obstetrics & Gynecology, 2018; 218(6): 602.e1- 602.e16.
26. Park HJ, Kim YS, Yoon TK, Lee WS. Chronic endometritis and infertility. Clinical and Experimental Reproductive Medicine, 2016; 43(4): 185–192.
27. Sfakianoudis K, Simopoulou M, Nikas Y, et al. Efficient treatment of chronic endometritis through a novel approach of intrauterine antibiotic infusion: a case series. BMC Womens Health, 2018; 18: 197.
28. Petrov YuA, Rymashevsky NV, Kovaleva EA. The effect of intrauterine contraceptives on the mucous membrane of the cervical canal and cervix. Problems of maternity and child care, 1987;8:59-61.
29. Vitagliano A, Saccardi C, Noventa M, et al. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure: A systematic review and meta‐analysis. Fertil Steril, 2018; 110: 103– 112.
30. Yang R, Du X, Wang Y, et al. The hysteroscopy and histological diagnosis and treatment value of chronic endometritis in recurrent implantation failure patients. Arch Gynecol Obstet, 2014; 289: 1363– 1369.